Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Field of Science
- 3.1 Basic medicine
Fingerprint
Dive into the research topics where Viktorija Ulanova is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Tuberculosis treatment: exploring the perspectives for personalized therapy
Bandere, D., Ulanova, V., Vīksna, A. & Sadovska, D.
1/01/21 → 31/12/23
Project: Fundamental and Applied Research Programme
-
Pharmacogenomics of drug resistant tuberculosis
Ranka, R., Bandere, D. & Ulanova, V.
1/04/22 → 30/04/23
Project: RSU grants
-
Assessment of genetic factors in tuberculosis cases
Ranka, R., Ulanova, V., Aļeiņikova, D. & Freimane, L.
1/09/20 → 31/08/21
Project: RSU grants
-
Assessment of Complete Blood Count-Derived Marker Association With Pulmonary Tuberculosis Severity and Treatment Response
Kivrane, A., Igumnova, V., Viksna, A., Simanovica, I., Ozere, I., Pole, I., Bandere, D. & Ranka, R., 2022, In: Medicina (Kaunas). 58, Suppl.1, p. 48 1 p.Research output: Contribution to journal › Meeting Abstract › peer-review
-
Development of rapid antigen test prototype for detection of SARS-CoV-2 in saliva samples
Kivrane, A., Igumnova, V., Liepina, E. E., Skrastina, D., Leonciks, A., Rudevica, Z., Kistkins, S., Reinis, A., Zilde, A., Kazaks, A. & Ranka, R., 25 Feb 2022, In: Upsala Journal of Medical Sciences. 127, 1, 9 p., e8207.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Citations (Scopus)1 Downloads (Pure) -
Importance of Clinical Pharmacogenetic-Pharmacokinetic Studies in Unravelling Determinants of Tuberculosis Treatment Outcomes: Findings and Implications in Latvia
Igumnova, V., Kivrane, A., Vīksna, A., Freimane, L., Sadovska, D., Čapligina, V., Pahirko, L., Ozere, I., Norvaiša, I., Bogdanova, I., Krams, A., Cīrule, A., Pugovičs, O., Grīnberga, S., Sevostjanovs, E., Bandere, D. & Ranka, R., 2022, In: Medicina (Kaunas). 58, Suppl.1, p. 47 1 p.Research output: Contribution to journal › Meeting Abstract › peer-review
-
Next-Generation Sequencing and Bioinformatics-Based Protocol for the Full-Length CYP2E1 Gene Polymorphism Analysis
Igumnova, V., Kivrane, A., Viksna, A., Norvaisa, I. & Ranka, R., 2022, In: Pharmacogenomics and Personalized Medicine. 15, p. 959-965 7 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile8 Downloads (Pure) -
Clinical and pharmacogenomic implications of xanthine dehydrogenase genetic variation in Latvian tuberculosis patients
Vīksna, A., Igumnova, V., Kivrāne, A., Freimane, L., Pole, I., Bandere, D., Ozere, I. & Ranka, R., 2021, In: Medicina (Kaunas). 57, Suppl.1, p. 258Research output: Contribution to journal › Meeting Abstract › peer-review
Activities
- 1 Oral presentation
-
Mapping the potential of pharmaco-metabolomics for personalized antituberculosis therapy
Viktorija Igumnova (Speaker)
24 Mar 2021Activity: Talk or presentation types › Oral presentation